JAMA Oncology

Second Primary Cancer After Chimeric Antigen Receptor–T-Cell Therapy – A Review

Importance  The commercialization of chimeric antigen receptor–T-cell (CAR-T) therapy has changed the landscape of treatment of hematological cancers. Numerous studies from the early 2000s paved the way for cell-based targeted therapeutics, which have been established as practice-changing therapies in lymphoma, leukemia,…

Initial Management of BRAF V600E-Variant Anaplastic Thyroid Cancer – The FAST Multidisciplinary Group Consensus Statement

Importance  BRAF/MEK inhibitors revolutionized the treatment of BRAF V600E-variant anaplastic thyroid carcinoma (BRAFv-ATC), offering improved outcomes for patients with this previously incurable disease. Observations  Anaplastic thyroid carcinoma (ATC) accounts for approximately half of thyroid cancer−related deaths. It presents as a rapidly growing tumor that…

BRCA1, BRCA2, and Associated Cancer Risks and Management for Male Patients – A Review

Importance  Half of all carriers of inherited cancer-predisposing variants in BRCA1 and BRCA2 are male, but the implications for their health are underrecognized compared to female individuals. Germline variants in BRCA1 and BRCA2 (also known as pathogenic or likely pathogenic variants, referred to here as BRCA1/2 PVs) are well known to…

Contemporary Management of Acute Myeloid Leukemia – A Review

Importance  Acute myeloid leukemia (AML) is a clonal hematopoietic cancer that disrupts normal hematopoiesis, ultimately leading to bone marrow failure and death. The annual incidence rate of AML is 4.1 per 100 000 people in the US and is higher in…

An Anal Lesion in a 27-Year-Old Patient

A 27-year-old male patient presented with anal discomfort and pruritus for 3 months. What is your diagnosis?

Recurrent Fevers in a Patient With Splenomegaly

A 36-year-old man presented with 10 weeks of recurrent fevers, malaise, night sweats, unintentional weight loss, and dyspnea. What is your diagnosis?